1. Home
  2. PDS vs NVAX Comparison

PDS vs NVAX Comparison

Compare PDS & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precision Drilling Corporation

PDS

Precision Drilling Corporation

HOLD

Current Price

$68.38

Market Cap

918.1M

Sector

N/A

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$6.56

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDS
NVAX
Founded
1951
1987
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
918.1M
1.1B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
PDS
NVAX
Price
$68.38
$6.56
Analyst Decision
Buy
Hold
Analyst Count
2
9
Target Price
$98.00
$10.78
AVG Volume (30 Days)
76.5K
3.5M
Earning Date
10-22-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.98
2.07
Revenue
$1,316,232,437.00
$1,064,651,000.00
Revenue This Year
N/A
$58.91
Revenue Next Year
$2.89
N/A
P/E Ratio
$23.04
$3.17
Revenue Growth
N/A
20.27
52 Week Low
$36.20
$5.01
52 Week High
$71.77
$11.55

Technical Indicators

Market Signals
Indicator
PDS
NVAX
Relative Strength Index (RSI) 67.77 39.00
Support Level $56.10 $6.43
Resistance Level $71.77 $6.84
Average True Range (ATR) 2.29 0.21
MACD 0.49 0.04
Stochastic Oscillator 77.87 23.95

Price Performance

Historical Comparison
PDS
NVAX

About PDS Precision Drilling Corporation

Precision Drilling Corp is a provider of contract drilling and completion and production services to oil and natural gas exploration and production companies in Canada, the United States, and certain international locations. Contract Drilling Services include drilling rigs, procurement and distribution of oilfield supplies, and the manufacture, sale and repair of drilling equipment. Completion and Production Services include service rigs, oilfield equipment rental, and camp and catering services.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: